Citation: Bmy. Keenoy et al., Divergent effects of different oxidants on glutathione homeostasis and protein damage in erythrocytes from diabetic patients: Effects of high glucose, MOL C BIOCH, 225(1-2), 2001, pp. 59-73
Authors:
Keenoy, BMY
Shen, HL
Engelen, W
Vertommen, J
Van Dessel, G
Lagrou, A
De Leeuw, I
Citation: Bmy. Keenoy et al., Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus, J NUTR, 131(6), 2001, pp. 1723-1730
Authors:
Mertens, I
Van der Planken, M
Corthouts, B
Wauters, M
Peiffer, F
De Leeuw, I
Van Gaal, L
Citation: I. Mertens et al., Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women, HORMONE MET, 33(10), 2001, pp. 602-607
Citation: K. Van Acker et al., The diabetic foot project of Flanders, the northern part of Belgium: Implementation of the St Vincent Consensus. Sensibilisation and registration in diabetes centres., ACT CLIN B, 56(1), 2001, pp. 21-31
Authors:
van der Planken, MG
Vertessen, FJ
Vertommen, J
Engelen, W
Berneman, ZN
De Leeuw, I
Citation: Mg. Van Der Planken et al., Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: No relationship with mean platelet volume or background retinopathy, CL APPL T-H, 6(2), 2000, pp. 65-68
Authors:
Engelen, W
Bouten, A
De Leeuw, I
De Block, C
Citation: W. Engelen et al., Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?, MAGNES RES, 13(3), 2000, pp. 197-203
Authors:
Van Acker, K
Oleen-Burkey, M
De Decker, L
Vanmaele, R
Van Schil, P
Matricali, G
De Leeuw, I
Citation: K. Van Acker et al., Cost and resource utilization for prevention and treatment of foot lesionsin a diabetic foot clinic in Belgium, DIABET RE C, 50(2), 2000, pp. 87-95
Authors:
Wauters, M
Considine, R
Lofgren, A
Van Broeckhoven, C
Van der Auwera, JC
De Leeuw, I
Van Gaal, L
Citation: M. Wauters et al., Associations of leptin with body fat distribution and metabolic parametersin non-insulin-dependent diabetic patients: No effect of apolipoprotein E polymorphism, METABOLISM, 49(6), 2000, pp. 724-730
Authors:
Engelen, W
Keenoy, BMY
Vertommen, J
De Leeuw, I
Citation: W. Engelen et al., Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes, AM J CLIN N, 72(5), 2000, pp. 1142-1149
Citation: C. De Block et I. De Leeuw, Associated thyrogastric autoimmunity increases the prevalence of low erythrocyte magnesium in type 1 diabetes, MAGNES RES, 12(4), 1999, pp. 279-285
Citation: Bmy. Keenoy et al., The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients, DIABET NUTR, 12(4), 1999, pp. 256-263
Authors:
Van Gaal, L
Mertens, I
Vansant, G
De Leeuw, I
Citation: L. Van Gaal et al., Carbohydrate-induced thermogenesis in obese women. Effect of insulin and catecholamines, J ENDOC INV, 22(2), 1999, pp. 109-114
Citation: Mp. Hermans et al., Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: Overview of pharmacological and clinical data, ACT CLIN B, 54(5), 1999, pp. 233-240
Authors:
Bex, M
Buysschaert, M
De Leeuw, I
De Schepper, J
Fery, F
Hermans, MP
Keymeulen, B
Lauvaux, JP
Letiexhe, M
Mathieu, C
Nobels, FR
Rottiers, R
Scheen, A
Schmitt, H
Van Crombrugge, P
Van Gaal, L
Citation: M. Bex et al., Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies, ACT CLIN B, 54(5), 1999, pp. 241-245
Citation: Fr. Nobels et al., Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue: Guidelines for its practical use, ACT CLIN B, 54(5), 1999, pp. 246-254